Laval University, Sainte-Foy
Researchers describe findings in hypertension studies
Published in Aging and Elder Health Week, November 27th, 2005
Study 1: Researchers have investigated the antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension in an 8-week, randomized, double-blind, parallel-group trial.
"Combination therapy with at least 2 antihypertensive agents is usually needed to achieve appropriate blood pressure (BP) control in patients with isolated or predominant systolic hypertension. A currently recommended combination is a diuretic added to an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
More Articles from Aging and Elder Health Week
- Breast Care Center of the Southwest, Phoenix
Insertion technique doesn't affect performance of MammoSite brachytherapy catheter - International Longevity Center
Survey reveals older Americans' attitudes toward sleep and healthy aging - Johns Hopkins School of Medicine
Reports describe recent advances in osteoporosis research - Kinetic Concepts, Inc.
Centers for Medicare and Medicare Services announces coding decision - Lincare Holdings Inc.
Respiratory home care services company reports impact of Medicare on revenues - Marshall Edwards, Inc.
Phenoxodiol may reverse gynecological cancer resistance to anticancer drugs - More from this issue of Aging and Elder Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
